See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus ...

Summary by Enid News & Eagle
EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals of Gilead’s Livdelzi (seladelpar) and Ipsen’s Iqirvo (elafibranor). These additions…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

GSK’s Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus ...

EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for primary biliary cholangitis (PBC) has undergone a marked transformation over the past year, driven by the recent approvals of Gilead’s Livdelzi (seladelpar) and Ipsen’s Iqirvo (elafibranor). These additions…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Thursday, July 17, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Exton, Pennsylvania icon

Exton, Pennsylvania

News
For You
SearchBlindspotLocal